Medios AG (ETR:ILM1)

Market Cap	306.07M
Revenue (ttm)	1.91B
Net Income (ttm)	14.94M
Shares Out	25.51M
EPS (ttm)	0.59
PE Ratio	20.31
Forward PE	11.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,809
Average Volume	39,350
Open	11.94
Previous Close	12.00
Day's Range	11.94 - 12.20
52-Week Range	9.98 - 18.50
Beta	1.20
RSI	52.48
Earnings Date	May 13, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 952
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.